Literature DB >> 23673149

Cyclodextrin-based supramolecular systems for drug delivery: recent progress and future perspective.

Jianxiang Zhang1, Peter X Ma.   

Abstract

The excellent biocompatibility and unique inclusion capability as well as powerful functionalization capacity of cyclodextrins and their derivatives make them especially attractive for engineering novel functional materials for biomedical applications. There has been increasing interest recently to fabricate supramolecular systems for drug and gene delivery based on cyclodextrin materials. This review focuses on state of the art and recent advances in the construction of cyclodextrin-based assemblies and their applications for controlled drug delivery. First, we introduce cyclodextrin materials utilized for self-assembly. The fabrication technologies of supramolecular systems including nanoplatforms and hydrogels as well as their applications in nanomedicine and pharmaceutical sciences are then highlighted. At the end, the future directions of this field are discussed.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Amphiphile; Cyclodextrin; Drug delivery; Gene therapy; Hydrogel; Nanomedicine; Nanoparticle; Self-assembly; Supramolecular system

Mesh:

Substances:

Year:  2013        PMID: 23673149      PMCID: PMC3885994          DOI: 10.1016/j.addr.2013.05.001

Source DB:  PubMed          Journal:  Adv Drug Deliv Rev        ISSN: 0169-409X            Impact factor:   15.470


  150 in total

1.  Cyclodextrins in targeting. Application to nanoparticles.

Authors: 
Journal:  Adv Drug Deliv Rev       Date:  1999-03-01       Impact factor: 15.470

2.  Highly soluble cyclodextrin derivatives: chemistry, properties, and trends in development.

Authors: 
Journal:  Adv Drug Deliv Rev       Date:  1999-03-01       Impact factor: 15.470

3.  Cyclodextrins in nasal drug delivery.

Authors: 
Journal:  Adv Drug Deliv Rev       Date:  1999-03-01       Impact factor: 15.470

4.  Cyclodextrins in transdermal and rectal delivery.

Authors: 
Journal:  Adv Drug Deliv Rev       Date:  1999-03-01       Impact factor: 15.470

5.  Cyclodextrins in ophthalmic drug delivery.

Authors: 
Journal:  Adv Drug Deliv Rev       Date:  1999-03-01       Impact factor: 15.470

6.  Cyclodextrins in peptide and protein delivery.

Authors: 
Journal:  Adv Drug Deliv Rev       Date:  1999-03-01       Impact factor: 15.470

7.  Cyclodextrin-based controlled drug release system.

Authors: 
Journal:  Adv Drug Deliv Rev       Date:  1999-03-01       Impact factor: 15.470

Review 8.  Polyrotaxanes: synthesis, structure, and potential in drug delivery.

Authors:  T Ooya; N Yui
Journal:  Crit Rev Ther Drug Carrier Syst       Date:  1999       Impact factor: 4.889

9.  Synthesis of theophylline-polyrotaxane conjugates and their drug release via supramolecular dissociation.

Authors:  T Ooya; N Yui
Journal:  J Control Release       Date:  1999-04-19       Impact factor: 9.776

10.  New class of polymers for the delivery of macromolecular therapeutics.

Authors:  H Gonzalez; S J Hwang; M E Davis
Journal:  Bioconjug Chem       Date:  1999 Nov-Dec       Impact factor: 4.774

View more
  82 in total

Review 1.  Supramolecular Hydrogelators and Hydrogels: From Soft Matter to Molecular Biomaterials.

Authors:  Xuewen Du; Jie Zhou; Junfeng Shi; Bing Xu
Journal:  Chem Rev       Date:  2015-12-08       Impact factor: 60.622

Review 2.  Self-Healing Supramolecular Hydrogels for Tissue Engineering Applications.

Authors:  Laura Saunders; Peter X Ma
Journal:  Macromol Biosci       Date:  2018-11-22       Impact factor: 4.979

Review 3.  Nanocaged platforms: modification, drug delivery and nanotoxicity. Opening synthetic cages to release the tiger.

Authors:  Mahdi Karimi; Parham Sahandi Zangabad; Fatemeh Mehdizadeh; Hedieh Malekzad; Alireza Ghasemi; Sajad Bahrami; Hossein Zare; Mohsen Moghoofei; Amin Hekmatmanesh; Michael R Hamblin
Journal:  Nanoscale       Date:  2017-01-26       Impact factor: 7.790

4.  TLR7/8-agonist-loaded nanoparticles promote the polarization of tumour-associated macrophages to enhance cancer immunotherapy.

Authors:  Christopher B Rodell; Sean P Arlauckas; Michael F Cuccarese; Christopher S Garris; Ran Li; Maaz S Ahmed; Rainer H Kohler; Mikael J Pittet; Ralph Weissleder
Journal:  Nat Biomed Eng       Date:  2018-05-21       Impact factor: 25.671

5.  Biodegradable β-Cyclodextrin Conjugated Gelatin Methacryloyl Microneedle for Delivery of Water-Insoluble Drug.

Authors:  Xingwu Zhou; Zhimin Luo; Avijit Baidya; Han-Jun Kim; Canran Wang; Xing Jiang; Moyuan Qu; Jixiang Zhu; Li Ren; Fereshteh Vajhadin; Peyton Tebon; Niyuan Zhang; Yumeng Xue; Yudi Feng; Chengbin Xue; Yi Chen; KangJu Lee; Junmin Lee; Shiming Zhang; Chun Xu; Nureddin Ashammakhi; Samad Ahadian; Mehmet Remzi Dokmeci; Zhen Gu; Wujin Sun; Ali Khademhosseini
Journal:  Adv Healthc Mater       Date:  2020-05-04       Impact factor: 9.933

6.  Nitric Oxide-Releasing Cyclodextrins.

Authors:  Haibao Jin; Lei Yang; Mona Jasmine R Ahonen; Mark H Schoenfisch
Journal:  J Am Chem Soc       Date:  2018-10-16       Impact factor: 15.419

7.  Remote loading of preencapsulated drugs into stealth liposomes.

Authors:  Surojit Sur; Anja C Fries; Kenneth W Kinzler; Shibin Zhou; Bert Vogelstein
Journal:  Proc Natl Acad Sci U S A       Date:  2014-01-28       Impact factor: 11.205

Review 8.  Polysaccharide-Based Controlled Release Systems for Therapeutics Delivery and Tissue Engineering: From Bench to Bedside.

Authors:  Tianxin Miao; Junqing Wang; Yun Zeng; Gang Liu; Xiaoyuan Chen
Journal:  Adv Sci (Weinh)       Date:  2018-01-08       Impact factor: 16.806

Review 9.  Use of Cyclodextrins in Anticancer Photodynamic Therapy Treatment.

Authors:  Amina Ben Mihoub; Ludivine Larue; Albert Moussaron; Zahraa Youssef; Ludovic Colombeau; Francis Baros; Céline Frochot; Régis Vanderesse; Samir Acherar
Journal:  Molecules       Date:  2018-08-02       Impact factor: 4.411

Review 10.  Clinical and pharmaceutical applications of affinity ligands in capillary electrophoresis: A review.

Authors:  Chenhua Zhang; Ashley G Woolfork; Kyungah Suh; Susan Ovbude; Cong Bi; Marawan Elzoeiry; David S Hage
Journal:  J Pharm Biomed Anal       Date:  2019-09-12       Impact factor: 3.935

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.